194 related articles for article (PubMed ID: 21652620)
1. Effect of azole antifungal therapy on vincristine toxicity in childhood acute lymphoblastic leukaemia.
van Schie RM; Brüggemann RJ; Hoogerbrugge PM; te Loo DM
J Antimicrob Chemother; 2011 Aug; 66(8):1853-6. PubMed ID: 21652620
[TBL] [Abstract][Full Text] [Related]
2. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
Harnicar S; Adel N; Jurcic J
J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
[TBL] [Abstract][Full Text] [Related]
3. Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia.
Jeng MR; Feusner J
Pediatr Hematol Oncol; 2001 Mar; 18(2):137-42. PubMed ID: 11255732
[TBL] [Abstract][Full Text] [Related]
4. [A retrospective analysis of neurotoxicity induced by vinca alkaloids combined with azole anti-fungal agents in hematological malignancies].
Osato Y; Yokoyama T; Saito Y; Kani R; Hayabe H; Miyamatsu H; Ohyashiki K
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1667-72. PubMed ID: 21996963
[TBL] [Abstract][Full Text] [Related]
5. Toxicity of Vincristine Combined With Posaconazole in Children With Acute Lymphoblastic Leukemia.
Pekpak E; İleri T; İnce E; Ertem M; Uysal Z
J Pediatr Hematol Oncol; 2018 Jul; 40(5):e309-e310. PubMed ID: 29219892
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of vincristine toxicity with concomitant fluconazole prophylaxis in children with acute lymphoblastic leukemia.
Teusink AC; Ragucci D; Shatat IF; Kalpatthi R
Pediatr Hematol Oncol; 2012 Feb; 29(1):62-7. PubMed ID: 22304011
[TBL] [Abstract][Full Text] [Related]
7. A trial to assess the efficacy of glutamic acid in prevention of vincristine-induced neurotoxicity in pediatric malignancies: a pilot study.
Mokhtar GM; Shaaban SY; Elbarbary NS; Fayed WA
J Pediatr Hematol Oncol; 2010 Nov; 32(8):594-600. PubMed ID: 20921909
[TBL] [Abstract][Full Text] [Related]
8. Vincristine-associated Neuropathy With Antifungal Usage: A Kaiser Northern California Experience.
Nikanjam M; Sun A; Albers M; Mangalindin K; Song E; Vempaty H; Sam D; Capparelli EV
J Pediatr Hematol Oncol; 2018 Jul; 40(5):e273-e277. PubMed ID: 29771861
[TBL] [Abstract][Full Text] [Related]
9. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
[TBL] [Abstract][Full Text] [Related]
10. Severe life threatening neurotoxicity in a child with acute lymphoblastic leukemia receiving posaconazole and vincristine.
Jain S; Kapoor G
Pediatr Blood Cancer; 2010 May; 54(5):783. PubMed ID: 20205256
[No Abstract] [Full Text] [Related]
11. Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia.
Fioredda F; Micalizzi C; Lanciotti M; Dufour C; Lamba LD; Fiocchi I
Med Pediatr Oncol; 2002 Aug; 39(2):141-2. PubMed ID: 12116067
[No Abstract] [Full Text] [Related]
12. Acute and long-term neurologic complications in children with acute lymphoblastic leukemia.
Aytaç S; Yetgin S; Tavil B
Turk J Pediatr; 2006; 48(1):1-7. PubMed ID: 16562778
[TBL] [Abstract][Full Text] [Related]
13. Itraconazole-enhanced vindesine neurotoxicity in adult acute lymphoblastic leukaemia.
Chen S; Wu D; Sun A; Qiu H; Jin Z; Tang X; Miao M; Fu Z; Ma X; Han Y; Hu X
Am J Hematol; 2007 Oct; 82(10):942. PubMed ID: 17617780
[No Abstract] [Full Text] [Related]
14. Vincristine-induced peripheral neuropathy in a neonate with congenital acute lymphoblastic leukemia.
Baker SK; Lipson DM
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e114-7. PubMed ID: 20216233
[TBL] [Abstract][Full Text] [Related]
15. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
[TBL] [Abstract][Full Text] [Related]
16. Vincristine-induced paralytic ileus during induction therapy of treatment protocols for acute lymphoblastic leukemia in adult patients.
Yasu T; Ohno N; Kawamata T; Kurokawa Y
Int J Clin Pharmacol Ther; 2016 Jun; 54(6):471-3. PubMed ID: 27087157
[TBL] [Abstract][Full Text] [Related]
17. Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions.
Yu DT; Peterson JF; Seger DL; Gerth WC; Bates DW
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):755-67. PubMed ID: 15654717
[TBL] [Abstract][Full Text] [Related]
18. Possible increase of the neurotoxicity of vincristine by the concurrent use of posaconazole in a young adult with leukemia.
Mantadakis E; Amoiridis G; Kondi A; Kalmanti M
J Pediatr Hematol Oncol; 2007 Feb; 29(2):130. PubMed ID: 17279013
[No Abstract] [Full Text] [Related]
19. Management of drug and food interactions with azole antifungal agents in transplant recipients.
Dodds-Ashley E
Pharmacotherapy; 2010 Aug; 30(8):842-54. PubMed ID: 20653361
[TBL] [Abstract][Full Text] [Related]
20. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia.
Reinders-Messelink HA; Van Weerden TW; Fock JM; Gidding CE; Vingerhoets HM; Schoemaker MM; Göeken LN; Bökkerink JP; Kamps WA
Eur J Paediatr Neurol; 2000; 4(5):225-33. PubMed ID: 11030069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]